Outcomes of endoscopic submucosal dissection for intestinal‐type adenocarcinoma with anastomosing glands of the stomach. Issue 1 (29th July 2019)

• Record Type: Journal Article
• Authors: Kim, Tae‐Se; Kim, Binnari; Min, Byung‐Hoon; Min, Yang Won; Lee, Hyuk; Lee, Jun Haeng; Rhee, Poong‐Lyul; Kim, Jae J; Kushima, Ryoji; Kim, Kyoung‐Mee
• Is Part Of: Journal of gastroenterology and hepatology. Volume 35:Issue 1(2020)
• Page Start: 50
• Page End: 55
• Publication Date: 2019-07-29
• Subjects: demography -- endoscopic mucosal resection -- pathology -- prognosis -- stomach neoplasms; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.14756
• Languages: English
• ISSNs: 0815-9319

Abstract

Abstract: Background and Aim: Gastric intestinal‐type adenocarcinoma with anastomosing glands (IAAG) is characterized by architectural abnormality with frequent anastomosing glands and low‐grade cytologic atypia. Clinicopathologic features and long‐term outcomes of endoscopic submucosal dissection (ESD) for IAAG remain unclear. Methods: This study included 2828 patients who underwent ESD for early gastric cancers (EGCs) (78 IAAGs [2.6%] and 2893 well‐differentiated [WD] or moderately differentiated [MD] EGCs [97.4%]). Clinicopathologic features and short‐term and long‐term outcomes of ESD for IAAG were reviewed and compared with those for WD or MD EGCs. Results: Gastric IAAGs were larger and more likely to be confined to the lamina propria than WD or MD EGCs. Histological heterogeneity, flat or depressed lesion and lateral resection margin (LRM) involvement were observed with significantly higher frequencies in IAAGs than in WD or MD EGCs. En bloc with R0 resection and curative resection rates of IAAGs were 79.5% and 73.1%, respectively, and both were significantly lower than those of WD or MD EGCs (93.8% and 82.9%). LRM involvement accounted for 57.1% of the non‐curative resection cases in gastric IAAGs. Half of IAAGs with LRM involvement had a crawling pattern at tumor periphery. Among patients undergoing curative ESD for IAAG, no recurrences occurred during a median 52 months of follow‐up. No lymph node metastasis was found in any of IAAG patients undergoing additional surgery after ESD. Conclusions: Gastric IAAGs have distinct clinicopathologic features from WD or MD EGCs. Given the favorable long‐term outcomes after curative resection, ESD can be indicated for early gastric IAAGs.